(Q73219209)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Etomoxir: a new approach to treatment of chronic heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

chronic heart failure

1 reference

M Bristow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1621-1622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

Regulation of glucose utilization during the inhibition of fatty acid oxidation in rat myocytes

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Why does the myocardium fail? Insights from basic science

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Etomoxir improves left ventricular performance of pressure-overloaded rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Modification of left ventricular hypertrophy by chronic etomixir treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903149-4

7 January 2021

10.1016/S0140-6736(00)03149-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089814%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference